News Semaglutide could transform diabetes treatment, revive Novo ... Oral formulation of GLP-1 drug could help cut heart attacks, tackle liver and kidney problems
News Novo Nordisk board member quits over NASH conflict of intere... Mary Szela has quit to avoid a conflict of interest.
News Novo enjoys strong Q1 as Trump price crackdown fails to mate... Novo Nordisk has shaken off fears of a drug pricing crackdown from president Donald Trump, after it beat profit forecasts in Q1 results.
News Keytruda in new lymphoma use leads latest CHMP decisions MSD keeps pressure on BMS with EU classical Hodgkin lymphoma indication.
News Novo Nordisk looking at M&A to revive fortunes, says CEO Novo Nordisk’s new CEO Lars Fruergaard Joergensen says it is considering M&A to shore up performance as its key US diabetes sales come under pressure.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
